Aim: The goal of this paper is to provide a protocol for conducting a fifth population-based Auckland Regional Community Stroke study (ARCOS V) in New Zealand. Methods and Discussion: In this study, for the first time globally, (1) stroke and TIA burden will be determined using the currently used clinical and tissue-based definition of stroke, in addition to the WHO clinical classifications of stroke used in all previous ARCOS studies, as well as more advanced criteria recently suggested for an “ideal” population-based stroke incidence and outcomes study; and (2) age, sex, and ethnic-specific trends in stroke incidence and outcomes will be determined over the last four decades, including changes in the incidence of acute cerebrovascular events over the last decade. Furthermore, information at four time points over a 40-year period will allow the assessment of effects of recent changes such as implementation of the FAST campaign, ambulance pre-notification, and endovascular treatment. This will enable more accurate projections for health service planning and delivery. Conclusion: The methods of this study will provide a foundation for future similar population-based studies in other countries and populations.
RothwellPM. The high cost of not funding stroke research: a comparison with heart disease and cancer. Lancet2001; 357: 1612–1616.
2.
FeiginVLForouzanfarMHKrishnamurthiR, et al.Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet2014; 383: 245–254.
3.
JohnstonSMendisSMathersC. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. Lancet Neurol2009; 8: 345–354.
4.
JohnsonCONguyenMRothGA, et al.Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol2019; 18: 439–58.
5.
FeiginVKrishnamurthiRBarker-ColloS, et al.30-Year trends in stroke rates and outcome in Auckland, New Zealand (1981–2012): a multi-ethnic population-based series of studies. PLoS One2015; 10(8): e0134609.
6.
KleindorferDPanagosPPancioliA, et al.Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke2005; 36: 720–723.
7.
BarberPAKrishnamurthiRParagV, et al.Incidence of transient ischemic attack in Auckland, New Zealand, in 2011 to 2012. Stroke2016; 47: 2183–2188.
8.
BrownP. Economic burden of stroke in New Zealand. In: Feigin VL (ed.) Three decades of Auckland Regional Community Stroke (ARCOS) studies: what have we learned and what is next for stroke care and stroke research2009; Vol 16Auckland: AUT University, pp. 20–24.
9.
AndersonCSCarterKNHackettML, et al.Trends in stroke incidence in Auckland, New Zealand, during 1981 to 2003. Stroke2005; 36: 2087–2093.
10.
CarterKAndersonCHacketM, et al.Trends in ethnic disparities in stroke incidence in Auckland, New Zealand, during 1981 to 2003. Stroke2006; 37: 56–62.
11.
ThriftAGThayabaranathanTHowardG, et al.Global stroke statistics. Int J Stroke2017; 12: 13–32.
12.
SaccoRLKasnerSEBroderickJP, et al.An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke2013; 44: 2064–2089.
13.
FeiginVLKrishnamurthiRVBarker-ColloS, et al.30-year trends in stroke rates and outcome in Auckland, New Zealand (1981-2012): a multi-ethnic population-based series of studies. PLoS One2015; 10: e0134609.
14.
TobiasM. Health loss in New Zealand 1990–2013: a report from the New Zealand burden of diseases, injuries and risk factors study, New Zealand: Ministry of Health, 2016.
15.
KrishnamurthiRVBarker-ColloSParagV, et al.Stroke incidence by major pathological type and ischemic subtypes in the Auckland regional community stroke studies: changes between 2002 and 2011. Stroke2018; 49: 3–10.
16.
Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Seattle, WA: IHME, University of Washington, https://vizhub.healthdata.org/gbd-compare/ (accessed 22 February 2019).
17.
SeshadriSBeiserAKelly-HayesM, et al.The lifetime risk of stroke: estimates from the Framingham Study. Stroke2006; 37: 345–350.
18.
FeiginVL, et al.The GBD 2016 lifetime risk of stroke collaborators. global, regional, and country-specific lifetime risks of stroke, 1990 and 2016. N Engl J Med2018; 379: 2429–2437.
19.
FeiginVNorrvingBSudlowCLMSaccoRL. Updated criteria for population-based stroke and transient ischemic attack incidence studies for the 21st century. Stroke2018; 49: 2248–2255.
20.
LiLYiinGGeraghtyO, et al.Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study. Lancet Neurol2015; 14: 903–13.
21.
RothwellPGilesMChandrathevaA, et al.Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet2007; 370: 1432–1442.
22.
AkedJDelavaranHNorrvingBLindgrenA. Temporal trends of stroke epidemiology in Southern Sweden: a population-based study on stroke incidence and early case-fatality. Neuroepidemiology2018; 50: 174–182.
23.
BahitMCoppolaMRiccioP, et al.First-ever stroke and transient ischemic attack incidence and 30-day case-fatality rates in a population-based study in Argentina. Stroke2016; 47: 1640–1642.
24.
CabralNFreireAConfortoA, et al.Increase of stroke incidence in young adults in a middle-income country a 10-year population-based study. Stroke2017; 48: 2925–2930.
25.
CabralNNagelVConfortoA, et al.Five-year survival, disability, and recurrence after first-ever stroke in a middle-income country: a population-based study in Joinvile, Brazil. Int J Stroke2018; 23: 115–119.
26.
KhanNMcAlisterFPiloteL, et al.Temporal trends in stroke incidence in South Asian, Chinese and white patients: a population based analysis. PLoS One2017; 12(5): e0175556.
27.
FeiginVCarterKHackettM, et al.Ethnic disparities in incidence of stroke subtypes: Auckland Regional Community Stroke Study, 2002-2003. Lancet Neurol2006; 5: 130–139.
28.
FeiginVMcNaughtonHDyallL. Burden of stroke in Maori and Pacific peoples of New Zealand. Int J Stroke2007; 2: 208–210.
29.
SandifordPSelakVGhafelM. Are ethnic inequalities in 30-day ischaemic stroke survival emerging as treatment becomes more effective?N Zealand Med J2016; 129: 8–14.
30.
AhoKHarmsenPHatanoSMarquardsenJSmirnovVStrasserT. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ1980; 58: 113.
31.
GloedeTHalbachSThriftADeweyHPfaffHCadilhacD. Long-term costs of stroke using 10-year longitudinal data from the North East Melbourne stroke incidence study. Stroke2014; 45: 3389–3394.
32.
KimHKimYSeoHKimEYoonSOhI. The economic burden of stroke in 2010 in Korea. J Korean Med Assoc2012; 55: 1226–1236.
33.
Kolominsky-RabasPHeuschmannPMarschallD, et al.Lifetime cost of ischemic stroke in Germany: results and national projections from a population-based stroke registry – the Erlangen Stroke Project. Stroke2006; 37: 1179–1183.
34.
Luengo-FernandezRGrayARothwellP. A population-based study of hospital care costs during 5 years after transient ischemic attack and stroke. Stroke2012; 43: 3343–3351.
35.
PerssonJFerraz-NunesJKarlbergI. Economic burden of stroke in a large county in Sweden. BMC Health Serv Res2012; 12: 341.
36.
Te AoBBrownPFeiginVAndersonC. Are stroke units cost effective? Evidence from a New Zealand stroke incidence and population-based study. Int J Stroke2012; 7: 623–630.
37.
EversSStruijsJAmentAvan GenugtenMJagerJvan den BosG. International comparison of stroke cost studies. Stroke2004; 35: 1209–1215.
38.
Te AoBBrownPFinkJVivianMFeiginV. Potential gains and costs from increasing access to thrombolysis for acute ischemic stroke patients in New Zealand hospitals. Int J Stroke2015; 10: 903–910.
FeiginVLLawesCMBennettDABarker-ColloSLParagV. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol2009; 8: 355–369.
41.
KrishnamurthiRJonesABarberPA, et al.Methodology of a population-based stroke and TIA incidence and outcomes study: the Auckland Regional Community Stroke Study (ARCOS IV) 2011-2012. Int J Stroke2014; 9: 140–147.
42.
BonitaRBeagleholeRNorthJD. Event, incidence and case fatality rates of cerebrovascular disease in Auckland, New Zealand. Am J Epidemiol1984; 120: 236–243.
43.
BonitaRBroadJBAndersonNEBeagleholeR. Approaches to the problems of measuring the incidence of stroke: the Auckland Stroke Study, 1991-1992. Int J Epidemiol1995; 24: 535–542.
44.
BonitaRBroadJBBeagleholeR. Changes in stroke incidence and case-fatality in Auckland, New Zealand, 1981-91. Lancet1993; 342: 1470–1473.
KrishnamurthiRJonesABarberP, et al.Methodology of a population-based stroke and TIA incidence and outcomes study: the Auckland Regional Community Stroke Study (ARCOS IV) 2011-2012. Int J Stroke2014; 9: 140–147.
47.
CorreiaMFonsecaACCanhãoP. Short-term outcome of patients with possible transient ischemic attacks: a prospective study. BMC Neurol2015; 15: 78.
48.
GoldsteinLJonesMMatcharD, et al.Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria. Stroke2001; 32: 1091–1097.
49.
AdamsHJrBendixenBKappelleL, et al.Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke1993; 24: 35–41.
KiyoharaTKamouchiMKumaiY, et al.ABCD3 and ABCD3-I scores are superior to ABCD2 score in the prediction of short- and long-term risks of stroke after Transient Ischemic Attack. Stroke2014; 45: 418–425.
52.
McLennonSBakasTJessupNHabermannBWeaverM. Task difficulty and life changes among stroke family caregivers: relationship to depressive symptoms. Arch Phys Med Rehab2014; 95: 1–7.
53.
BakasTJessupNMcLennonSHabermannBWeaverMMorrisonG. Tracking patterns of needs during a telephone follow-up programme for family caregivers of persons with stroke. Disab Rehab2016; 18: 1780–1791.
54.
RankinJ. Cerebral vascular accidents in patients over the age of 60. II. prognosis. Scottish Med J1957; 2(5): 200–215.
55.
ZigmondASnaithR. The hospital anxiety and depression scale. Acta Psychiat Scand1983; 67: 361–370.
56.
NasreddineZPhillipsNBédirianV, et al.The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc2005; 53: 695–699.
57.
KruppLLaRoccaNMuir-NashJSteinbergA. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol1989; 46: 1121–1123.
58.
EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy1990; 16: 199–208.
59.
KeithRGrangerCHamiltonBSherwinF. The functional independence measure: a new tool for rehabilitation. Adv Clin Rehab1987; 1: 6–18.
60.
SchiaritiVSelbMCiezaAO’DonnellM. International classification of functioning, disability and health core sets for children and youth with cerebral palsy: a consensus meeting. Develop Med Child Neurol2015; 57: 149–158.
61.
SaccoRKasnerSBroderickJ, et al.An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American heart association/American stroke association. Stroke2013; 44: 2064–2089.
62.
HarrisPTaylorRThielkeRPayneJGonzalezNCondeJ. Research electronic data capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed inform2009; 42: 377–381.
63.
GuKNgHManLSchucanyW. Testing the ratio of two poisson rates. Biometric J2008; 50: 283–298.
LindseyJK. Models for repeated measurements, Oxford: Oxford University Press, 1993.
66.
ExeterDJZhaoJCrengleSLeeABrowneM. The New Zealand Indices of Multiple Deprivation (IMD): a new suite of indicators for social and health research in Aotearoa, New Zealand. PLoS One2017; 12: e0181260.
67.
HosmerDHosmerTLe CessieSLemeshowS. A comparison of goodness‐of‐fit tests for the logistic regression model. Stat Med1997; 16: 965–980.
68.
HarrellFLeeKMarkD. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med1996; 15: 361–387.
69.
MarquesEJohnsonEGooberman-HillRBlomANobleS. Using resource use logs to reduce the amount of missing data in economic evaluations alongside trials. Value Health2013; 16: 195–201.
70.
HusereauDDrummondMPetrouS, et al.Consolidated health economic evaluation reporting standards (CHEERS) statement. Cost Effective Res Alloc2013; 11: 6.
71.
FeiginVNorrvingBSudlowCLSaccoRL. Updated criteria for population-based stroke and transient ischemic attack incidence studies for the 21st century. Stroke2018; 49(9): 2248–2255.
72.
FeiginVLNorrvingBMensahGA. Global burden of stroke. Circul Res2017; 120: 439–448.
